论文信息 - Clinical efficacy and tolerance of oral low-dose continuous estrogen-progestin therapy (Activelle)

Clinical efficacy and tolerance of oral low-dose continuous estrogen-progestin therapy (Activelle)

W pracy przedstawiono ocenê nowej terapeutycznej opcji hormonalnej terapii zastêpczej – doustnej niskodawkowej ciaglej terapii z3o¿onej estrogenowo-gestagenowej z u¿yciem 1 mg estradiolu i 0,5 mg octanu norethisteronu. Stwierdzono, ¿e preparat Activelle (Novo Nordisk) jest skuteczny w leczeniu objawów menopauzalnych. Lek ten by3 dobrze tolerowany przez kobiety w wieku pomenopauzalnym. Czêstoœæ objawów ubocznych by3a niska. Plamienie/krwawienie stwierdzano u 22,6% pacjentek w 1. mies. HRT i u 6,9% leczonych po 6 mies.

J. Suzin | E. Wlazlak | G. Surkont

[1] H. Mizunuma,et al. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study. , 1997, Maturitas.

[2] S. Evans,et al. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post‐menopausal ages , 1996, Clinical endocrinology.

[3] L. Mattsson,et al. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. , 1996, Maturitas.

[4] M. Dören,et al. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. , 1995, American journal of obstetrics and gynecology.

[5] I. Wiklund,et al. A quality of life perspective on who benefits from estradiol replacement therapy , 1995, Acta obstetricia et gynecologica Scandinavica.

[6] C. Joyce,et al. Quality of life after the menopause: influence of hormonal replacement therapy. , 1994, American journal of obstetrics and gynecology.

[7] A. Drogendijk,et al. Women's opinion on withdrawal bleeding with hormone replacement therapy. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[8] C. Christiansen,et al. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. , 1990, The Journal of clinical endocrinology and metabolism.